This is the authors' abstract. We don't add key points for this paper.
Thirteen oral cephems (cefprozil, loracarbef, cefaclor, cefuroxime axetil, cefpodoxime proxetil, cefetamet pivoxil, cefixime, cefdinir, cefadroxil, cephradine, cephalexin, cefatrizine, and cefroxadine), the cephalosporin class representative cephalothin, cefazolin, and the macrolides erythromycin, clarithromycin, and azithromycin were compared for their antibacterial activities against 790 recent clinical isolates. These oral agents differed in their spectra and antibacterial potencies against community-acquired pathogens.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fung-Tomc et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: